Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples